$2.67 Billion is the total value of PFM Health Sciences, LP's 68 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | HORIZON THERAPEUTICS PUB L | $114,872,000 | -2.4% | 1,091,840 | 0.0% | 4.30% | +7.2% | |
| RCUS | ARCUS BIOSCIENCES INC | $108,283,000 | -22.0% | 3,431,010 | 0.0% | 4.05% | -14.4% | |
| CNC | CENTENE CORP DEL | $93,660,000 | +2.2% | 1,112,480 | 0.0% | 3.50% | +12.2% | |
| CYTK | CYTOKINETICS INC | $90,737,000 | -19.2% | 2,465,016 | 0.0% | 3.39% | -11.3% | |
| LLY | LILLY ELI & CO | $85,522,000 | +3.7% | 298,643 | 0.0% | 3.20% | +13.8% | |
| AVTR | AVANTOR INC | $70,334,000 | -19.7% | 2,079,657 | 0.0% | 2.63% | -11.9% | |
| PFE | PFIZER INC | $69,547,000 | -12.3% | 1,343,384 | 0.0% | 2.60% | -3.7% | |
| UNH | UNITEDHEALTH GROUP INC | $56,889,000 | +1.6% | 111,554 | 0.0% | 2.13% | +11.5% | |
| DHR | DANAHER CORPORATION | $51,535,000 | -10.8% | 175,690 | 0.0% | 1.93% | -2.1% | |
| ICUI | ICU MED INC | $49,111,000 | -6.2% | 220,587 | 0.0% | 1.84% | +3.0% | |
| BIOMARIN PHARMACEUTICAL INCnote 0.599% 8/0 | $46,002,000 | -4.4% | 45,910,000 | 0.0% | 1.72% | +5.0% | ||
| AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $43,919,000 | +9.1% | 48,150,000 | 0.0% | 1.64% | +19.8% | ||
| DVAX | DYNAVAX TECHNOLOGIES CORP | $41,250,000 | -23.0% | 3,805,370 | 0.0% | 1.54% | -15.4% | |
| ICLR | ICON PLC | $38,473,000 | -21.5% | 158,183 | 0.0% | 1.44% | -13.7% | |
| TMO | THERMO FISHER SCIENTIFIC INC | $36,705,000 | -11.5% | 62,143 | 0.0% | 1.37% | -2.8% | |
| WAT | WATERS CORP | $36,512,000 | -16.7% | 117,634 | 0.0% | 1.36% | -8.5% | |
| CAH | CARDINAL HEALTH INC | $36,276,000 | +10.1% | 639,783 | 0.0% | 1.36% | +20.9% | |
| JNCE | JOUNCE THERAPEUTICS INC | $26,976,000 | -18.7% | 3,972,868 | 0.0% | 1.01% | -10.6% | |
| ANTM | ANTHEM INC | $20,992,000 | +6.0% | 42,734 | 0.0% | 0.78% | +16.5% | |
| HRTX | HERON THERAPEUTICS INC | $20,091,000 | -37.3% | 3,512,348 | 0.0% | 0.75% | -31.2% | |
| ISEE | IVERIC BIO INC | $16,918,000 | +0.7% | 1,005,216 | 0.0% | 0.63% | +10.7% | |
| AERI | AERIE PHARMACEUTICALS INC | $9,906,000 | +29.6% | 1,088,566 | 0.0% | 0.37% | +42.3% | |
| IO BIOTECH INC | $6,649,000 | -14.1% | 1,362,144 | 0.0% | 0.25% | -5.7% | ||
| JYAC | JIYA ACQUISITION CORP | $4,562,000 | +0.6% | 464,103 | 0.0% | 0.17% | +11.0% | |
| BLSA | BCLS ACQUISITION CORP | $4,581,000 | +0.7% | 464,103 | 0.0% | 0.17% | +10.3% | |
| FLDM | FLUIDIGM CORP DEL | $3,520,000 | -8.4% | 980,505 | 0.0% | 0.13% | +0.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MOLINA HEALTHCARE INC | 41 | Q3 2023 | 2.2% |
| HCA HOLDINGS INC | 38 | Q3 2023 | 5.2% |
| HUMANA INC | 37 | Q3 2023 | 3.8% |
| EDWARDS LIFESCIENCES CORP | 36 | Q3 2023 | 3.3% |
| UNITEDHEALTH GROUP INC | 33 | Q3 2023 | 4.8% |
| PENUMBRA INC | 33 | Q3 2023 | 4.8% |
| AERIE PHARMACEUTICALS INC | 28 | Q2 2022 | 3.7% |
| TENET HEALTHCARE CORP | 27 | Q3 2023 | 2.3% |
| ELEVANCE HEALTH INC | 26 | Q3 2023 | 4.2% |
| ICON PLC | 26 | Q3 2023 | 2.5% |
View PFM Health Sciences, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adaptimmune Therapeutics PLC | February 14, 2023 | ? | ? |
| Arcus Biosciences, Inc. | February 14, 2023 | ? | ? |
| Axsome Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Erasca, Inc. | February 14, 2023 | ? | ? |
| Generation Bio Co. | February 14, 2023 | ? | ? |
| IO Biotech, Inc. | February 14, 2023 | ? | ? |
| Jounce Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Outset Medical, Inc. | February 14, 2023 | ? | ? |
| uniQure N.V. | February 14, 2023 | ? | ? |
| AERIE PHARMACEUTICALS INC | February 14, 2022 | ? | ? |
View PFM Health Sciences, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-04-21 |
View PFM Health Sciences, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.